Wave Life Sciences (WVE) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to earnings of $0.07 per share a year ago. These ...

Watertown, Mass., added millions of square feet of lab space in just a few years. Here's how it happened, and why the pace ...

The campaign we have all just gone through has not been very focused on a lot of policy detail," said Buchanan Ingersoll & ...

McNamara’s extensive experience in scaling imaging and eClinical companies through organic growth and acquisition strategies ...

The U.S. life sciences development bubble burst at the start of 2024, and it is going to take some time simply to pick up the pieces. There are already signs of recovery for the new year, though.

Goodwin is presenting a two-part publication series covering life sciences trends involving license deals, M&A, and financing for Greater China’s ...

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Greetings, and welcome ...

Roth MKM analyst Jason Wittes initiated coverage of TriSalus Life Sciences (TLSI) with a Buy rating and $11 price target The company’s ...

Vita Life Sciences Limited (AU:VLS) has released an update. Vita Life Sciences Limited has announced its ongoing on-market ...

It looked like any other athletic signing day — except instead of athletes signing to the university, it was life science ...

This 18th-20th February, 2025, London will host the premier HR event for European Life Sciences. Join CHROs, CPOs, and HR ...